Possible Future Avenues for Rheumatoid Arthritis Therapeutics: Hippo Pathway

References

• Lubberts E. Role of T lymphocytes in the development of rheumatoid arthritis. Implications for treatment. Curr Pharm Des. 2014;21(2):142–146. doi:10.2174/1381612820666140825122247
   Google Scholar
• Feldmann M. Clinical research progress on the pathogenesis of rheumatoid arthritis. Clin Med. 2012;42(07):123–125.
   Google Scholar
• Kojima F, Sekiya H, Hioki Y. Facilitation of colonic T cell immune responses is associated with an exacerbation of dextran sodium sulfate-induced colitis in mice lacking microsomal prostaglandin E synthase-1. Inflamm Regen. 2022;42:1. doi:10.1186/s41232-021-00188-1
   PubMedGoogle Scholar
• Zaid T, Janse van Rensburg Helena J, Xiaolong Y. The Hippo Pathway: immunity and cancer. Cancers. 2018;10:4.
   Google Scholar
• Yuting S, De J, Ziwei Z, et al. The critical role of the Hippo pathwayHippo pathway in kidney diseases. Front Pharmacol. 2022;13:1.
   Google Scholar
• Yu FX, Zhao B, Guan KL. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell. 2015;163(4):811–828.
   PubMed Web of Science ®Google Scholar
• Hong L, Li X, Zhou D, et al. Role of Hippo signaling in regulating immunity. Cell Mol Immunol. 2018;15(12):1003–1009.
   PubMedGoogle Scholar
• Geng J, Yu S, Zhao H, et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of Th17 cells and Treg cells. Nat Immunol. 2017;18(7):800–812.
   PubMed Web of Science ®Google Scholar
• Mou F, Praskova M, Xia F, et al. The Mst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J Exp Med. 2012;209(4):741–759.
   PubMedGoogle Scholar
• Samson M, Audia S, Janikashvili N, et al. Brief report: inhibition of interleukin-6 function corrects Th17 / Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheumatism. 2012;64(8):2499–2503.
   PubMedGoogle Scholar
• Creasy CL, Chernoff J. Cloning and characterization of a member of the MST subfamily of Ste20-like kinases. Gene. 1995;167(1–2):303–306.
   PubMedGoogle Scholar
• Creasy CL, Chernoff J. Cloning and characterization of a human protein kinase with homology to Ste20. J Biol Chem. 1995;270(37):21695–21700.
   PubMedGoogle Scholar
• Tao WF, Zhang S, Turenchalk GS, et al. Human homologue of the drosophila melanogaster lats tumour suppressor modulates CDC2 activity. Nat Genet. 1999;21(2):177–181.
   PubMedGoogle Scholar
• Bichsel SJ, Tamaskovic R, Stegert MR, Hemmings BA. Mechanism of activation of NDR (nuclear Dbf2-related) protein kinase by the hMOB1 protein. J Biol Chem. 2004;279(34):35228–35235.
   PubMedGoogle Scholar
• Tapon N, Harvey KF, Bell DW, et al. Salvador promotes both cell cycle exit and apoptosis in drosophila and is mutated in human cancer cell lines. Cell. 2002;110(4):467–478.
   PubMed Web of Science ®Google Scholar
• Sudol M. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the YES proto-oncogene product. Oncogene. 1994;9(8):2145–2152.
   PubMed Web of Science ®Google Scholar
• Kanai F, Marignani PA, Sarbassova D, et al. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J. 2000;19(24):6778–6791.
   PubMedGoogle Scholar
• Halder G, Johnson RL. Hippo signaling: growth control and beyon. Development. 2011;138(1):9–22.
   PubMed Web of Science ®Google Scholar
• Pan D. The Hippo pathway in development and cancer. Dev Cell. 2010;19(4)):491–505.
   PubMedGoogle Scholar
• Zhou DW, Conrad C, Xia F, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the YAP1 oncogene. Cancer Cell. 2009;16(5):425–438.
   PubMed Web of Science ®Google Scholar
• Zhou DW, Medoff BD, Chen LF, et al. The Nore1b/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proc Natl Acad Sci USA. 2008;105(51):20321–20326.
   PubMedGoogle Scholar
• Zhou DW, Zhang YY, Wu HT, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of yes-associated protein (YAP) overabundance. Proc Natl Acad Sci USA. 2011;108(49):E1312–E1320.
   PubMed Web of Science ®Google Scholar
• Lee KP, Lee JH, Kim TS, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA. 2010;107(18):8248–8253.
   PubMedGoogle Scholar
• Lu L, Li Y, Kim SM, et al. signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA. 2010;107(4):1437–1442.
   PubMed Web of Science ®Google Scholar
• Song H, Mak KK, Topol L, et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA. 2010;107(4):1431–1436.
   PubMed Web of Science ®Google Scholar
• Heallen T, Zhang M, Wang J, et al. Hippo pathway inhibits wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458–461.
   PubMed Web of Science ®Google Scholar
• Gao T, Zhou DW, Yang CH, et al. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology. 2013;144(7):1543–1553.e1.
   PubMedGoogle Scholar
• Zhou D, Zhang Y, Wu H, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (YAP) overabundance. Proc Natl Acad Sci USA. 2011;108(49):E1312–E1320.
   PubMed Web of Science ®Google Scholar
• Zhang N, Bai H, David KK, et al. The Merlin /NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell. 2010;19(1):27–38.
   PubMed Web of Science ®Google Scholar
• Zhao B, Wei X, Li W, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747–2761.
   PubMed Web of Science ®Google Scholar
• Hao Z, Yiran S, Jin-Jia Z, et al. Non-canonical Hippo pathway regulates immune homeostasis. J Xiamen Univ. 2021;61(03):377–386.
   Google Scholar
• Zhou D, Medoff BD, Chen L, et al. The Nore1B /Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proc Natl Acad Sci USA. 2008;105(51):20321–20326.
   PubMedGoogle Scholar
• Yuan ZQ, Lehtinen MK, Merlo P, Villén J, Gygi S, Bonni A. Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem. 2009;284(17):11285–11292.
   PubMed Web of Science ®Google Scholar
• Geng J, Sun X, Wang P, et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol. 2015;16(11):1142–1152.
   PubMed Web of Science ®Google Scholar
• Liu B, Zheng Y, Yin F, et al. Toll receptor-mediated hippo signaling controls innate immunity in Drosophila. Cell. 2016;164(3):406–419.
   PubMedGoogle Scholar
• Wang S, Xie F, Chu F, et al. YAP antagonizes innate antiviral immunity and is targeted for lysosomal degradation through IKKε-mediated phosphorylation. Nat Immunol. 2017;18(7):733–743.
   PubMedGoogle Scholar
• Zhang Q, Meng F, Chen S, et al. Hippo signalling governs cytosolic nucleic acid sensing through YAP / TAZ-mediated TBK1blockade. Nat Cell Biol. 2017;19(4):362–374.
   PubMed Web of Science ®Google Scholar
• Fallahi E, O’Driscoll NA, Matallanas D. The MST/Hippo Pathway and cell death: a non-canonical affair. Genes. 2016;7(6):28.
   PubMedGoogle Scholar
• Furth N, Aylon Y, Oren M. p53 shades of Hippo. Cell Death Differ. 2018;25:81–92.
   PubMed Web of Science ®Google Scholar
• Zhou D, Medoff BD, Chen LF, et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. Proc Natl Acad Sci USA. 2008;105(51):20321–20326.
   PubMedGoogle Scholar
• Geng J, Hong LX, Chen LF. Research progress of Hippo pathway related molecules involved in the regulation of immune cell function. Bioscience. 2017;29(9):908–915.
   Google Scholar
• Yu-jie D, Jin-qiu L, Wen-ling L, et al. Reciprocal inhibition of YAP/TAZ and NF- κB regulates osteoarthritic cartilage degradation. Nat Commun. 2018;9(1):4564.
   PubMedGoogle Scholar
• Abdollahpour H, Appaswamy G, Kotlarz D, et al. The phenotype of human STK4 deficiency. Blood. 2012;119(15):3450–3457.
   PubMed Web of Science ®Google Scholar
• Nehme NT, Schmid JP, Debeurme F, et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naïve T-cell survival. Blood. 2012;119(15):3458–3468.
   PubMedGoogle Scholar
• Dong Y, Du X, Ye J, et al. A cell intrinsic role for Mstl in regulating thymocyte egress. J Immunol. 2009;183(6):3865–3872.
   PubMedGoogle Scholar
• Du X, Shi H, Li J, et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1 / Foxo3 stability in autoimmune disease. J Immunol. 2014;192(4):1525–15 35.
   PubMed Web of Science ®Google Scholar
• Du XR, Shi H, Li J, et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J Immunol. 2014;192(4)::1525–1535.
   PubMed Web of Science ®Google Scholar
• Tomiyama T, Ueda Y, Katakai T, Kondo N, Okazaki K, Kinashi T. Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mst1 kinase. PLoS One. 2013;8(9):e73874.
   PubMedGoogle Scholar
• Jun-Hong L, Hu-Yue-yue L, Lan-fen C. Research progress of Hippo pathway in regulating the maintenance of immune cell homeostasis. Chin J Immunol. 2019;35(15):1793–1801.
   Google Scholar
• Geng J, Yu SJ, Zhao H, et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. Nat Immunol. 2017;18(7):800–812.
   PubMed Web of Science ®Google Scholar
• Xin L, Xiong C, Liang L. Research progress on the role of Th17 cells in the pathogenesis of rheumatoid arthritis. Chin Pharmacol Bull. 2020;36(3)::309–12.
   Google Scholar
• Feng Z, Zongshun D, Lin Y, et al. Study on the molecular mechanism of “wind, cold and damp” affecting Th17/Treg imbalance and promoting rheumatoid arthritis syndrome. J Hum Univ Trad Chin Med. 2021;41(11):1657–1662.
   Google Scholar
• Weiqi Z, Xu L, Cheng ZY, et al. Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease. Eur J Immunol. 2021;51:9.
   Google Scholar
• Geng J, Sun XF, Wang P, et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat Immunol. 2015;16(11):1142–1152.
   PubMed Web of Science ®Google Scholar
• Tomiyama T, Ueda Y, Katakai T, et al. Antigen-specific suppression and immunological synapse formation by regulatory T cells require the Mstl kinase. PLoS One. 2013;8(9):e73874.
   PubMedGoogle Scholar
• Li XJ, Park ES, Park MH, et al. 3,3’-Diindolylmethane suppresses the growth of gastric cancer cells via activation of the Hippo signaling pathway. Oncol Rep. 2013;30(5):2419–2426.
   PubMed Web of Science ®Google Scholar
• Salojin KV, Hamman BD, Chang WC, et al. Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. PLoS One. 2014;9:e98151.
   PubMedGoogle Scholar
• Chen X. The Role and Clinical Significance of TAZ in the Pathogenesis of Rheumatoid Arthritis. Xiamen University; 2019.
   Google Scholar
• Liu L, Ji Y, Zu B, et al. Acacetin regulated the reciprocal differentiation of Th17 cells and Treg cells and mitigated the symptoms of collagen-induced arthritis in mice. Scand J Immunol. 2018;88(4):el2712.
   Google Scholar
• Wu J, Yang XH, Ma L, et al. Effects of miR-26a-5p on apoptosis of human rheumatoid arthritis fibroblast-like synoviocytes through JAK2/STAT3 signaling pathway. J Jilin Univ. 2021;47(2):460–468.
   Google Scholar
• Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9(1):24–33.
   PubMed Web of Science ®Google Scholar
• Piccolo S, Dupont S, Cordenonsi M. The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev. 2014;94(4):1287–1312.
   PubMed Web of Science ®Google Scholar
• Bottini A, Wu DJ, Ai R, et al. PTPN14 phosphatase andYAP promote TGFβ signalling in rheumatoid synoviocytes. Ann Rheum Dis. 2019;78(5):600–609.
   PubMedGoogle Scholar
• Wang Z, Lu W, Zhang Y, et al. The Hippo Pathway and viral infections. Front Microbiol. 2019;10:3033.
   PubMedGoogle Scholar
• Zhang S, Chen Q, Liu Q, et al. Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2. Cancer Cell. 2017;31(5):669–684.e7.
   PubMedGoogle Scholar
• Robin C, Estelle A, Guillaume C, et al. YAP/TAZ: key players for rheumatoid arthritis severity by driving fibroblast like synoviocytes phenotype and fibro-inflammatory response. Front Immunol. 2021;12:1.
   Google Scholar
• Pai-Pi G. The Mechanism of GRK2 Shutting Down Hippo-YAP Signaling to Promote Abnormal Proliferation of Fibroblast-Like Synoviocytes. Anhui Medical University; 2021.
   Google Scholar
• Sheng Q. Knockdown of YAP and TAZ Inhibit the Migration and Invasion of RA-FLS by Regulating Autophagy. Yangzhou University; 2019.
   Google Scholar
• Totaro A, Panciera T, Piccolo S. YAP/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018;20(8)::888–899.
   PubMed Web of Science ®Google Scholar
• He L, Pratt H, Gao M, et al. YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation. Elife. 2021;10:e67312.
   PubMedGoogle Scholar
• Caire R, Audoux E, Courbon G, et al. YAP/TAZ: key players for rheumatoid arthritis severity by driving fibroblast like synoviocytes phenotype and fibro-inflammatory response. Front Immunol. 2021;12:1.
   Google Scholar
• Zhou W, Shen Q, Wang H, et al. Knockdown of YAP/TAZ inhibits the migration and invasion of fibroblast synovial cells in rheumatoid arthritis by regulating autophagy. J Immunol Res. 2020;2020:1.
   Google Scholar
• Roelofs AJ, Zupan J, Riemen AHK, et al. Joint morphogenetic cells in the adult mammalian synovium. Nat Commun. 2017;8:15040.
   PubMedGoogle Scholar
• Baum R, Gravallese EM. Impact of inflammation on the osteoblast in rheumatic diseases. Curr Osteo Poros Rep. 2014;12(1):9–16.
   PubMedGoogle Scholar
• Okamoto K, Nakashima T, Shinohara M, et al. Osteoim munology: the conceptual framework unifying the immune and skeletal systems. Physiol Rev. 2017;97(4):1295–1349.
   PubMed Web of Science ®Google Scholar
• Zhao L, Guan H, Song C, et al. YAP1 is essential for osteoclastogenesis through a TEADs-dependent mechanism. Bone. 2018;110:177–186.
   PubMedGoogle Scholar
• Aoyama E, Kubota S, Khattab HM, et al. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG. Bone. 2015;73:242–248.
   PubMedGoogle Scholar
• Wanlei Y, Xuanyuan L, Tan Z, et al. TAZ inhibits osteoclastogenesis by attenuating TAK1/NF-κB signaling. Bone Res. 2021;9(1):1–10.
   PubMedGoogle Scholar
• Wan-lei Y, Wei-qi H, Qin A, et al. The emerging role of Hippo pathway in regulating osteoclast formation. J Cell Physiol. 2018;233(6):4606–4617.
   PubMedGoogle Scholar
• Lee J, Youn BU, Kim K, et al. Mst2 controls bone homeostasis by regulating osteoclast and osteoblast differentiation. J Bone Miner Res. 2015;30(9):1597–1607.
   PubMedGoogle Scholar
• Oh S, Lee D, Kim T, et al. Crucial role for Mst1 and Mst2 kinases in early embryonic development of the mouse. Mol Cell Biol. 2009;29(23):6309–6320.
   PubMedGoogle Scholar
• Feng YC. Expression and Clinical Study of Serum MST1 Kinase Level in Rheumatoid Arthritis. Lanzhou: The Second Clinical Medical College of Lanzhou University; 2019.
   Google Scholar
• Siyu S, Xiaodong F. Clinical research progress of joint pain in systemic lupus erythematosus. Chin J Pain Med. 2016;22:141–143.
   Google Scholar
• Zhang SD, Wang YQ, Liu YW, et al. Research progress of traditional Chinese medicine in delaying the process of bone erosion in rheumatoid arthritis. Chin J Trad Chin Med. 2021;37(2):321–325.
   Google Scholar
• Fu SD. Advances in new target drugs for rheumatoid arthritis. Chin J Drug Eval. 2012;39(1):44–47.
   Google Scholar
• Schoels M, Aletaha D, Smolen JS, Wong JB. Comparative effectiveness and safety of biological treatment options after tumour necrosis factor alpha inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis. Ann Rheum Dis. 2012;71(8):1303–1308.
   PubMed Web of Science ®Google Scholar
• Smolen JS, Kay J, Matteson EL, et al. Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study. Ann Rheum Dis. 2014;73(10):1811–1818.
   PubMed Web of Science ®Google Scholar
• Ruihua L, Zengyu C, Haodong X, et al. Research progress on influencing factors of bone destruction in rheumatoid arthritis. Chinese Med Guide. 2022;19(35):36–39+65.
   Google Scholar
• Aletaha D, Smolen JS. Joint damage in rheumatoid arthritis progresses in remission according to the disease activity score in 28 joints and is driven by residual swollen joints. Arthritis Rheum. 2011;63(12):3702–3711.
   PubMedGoogle Scholar
• Binder NB, Puchner A, Niederreiter B, et al. Tumor necrosis factor-inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor-driven model of rheumatoid arthritis. Arthritis Rheum. 2013;65(3):608–617.
   PubMedGoogle Scholar
• Smolen JS, Han C, Bala M, et al. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Arthritis Rheum. 2005;52(4):1020–1030.
   PubMedGoogle Scholar
• Qianwen Y, Yusong W, Fen L. Research progress on the mechanism of drugs for the treatment of rheumatoid arthritis. Chin J Med Front. 2020;12(11):4–8.
   Google Scholar
• Burmester GR, Pope JE. Novel treatment strategies in rheumatoid arthritis. Lancet. 2017;389(10086):2338–2348.
   PubMed Web of Science ®Google Scholar
• Papadaki G, Goutakoli P, Tiniakou I, et al. IL-6 signaling attenuates TNF-α production by plasmacytoid dendritic cells in rheumatoid arthritis. J Immunol. 2022;2022:1.
   Google Scholar
• Lefeng C, Jianda M, Qianhua L, Yi D. Effect of compliance with biological agents on treatment target of rheumatoid arthritis. New Medi. 2019;50(05):313–318.
   Google Scholar